Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 30, 2009
Impact of the ASCO 2007 presentation of HOG Lun 01-24/USO-023 on the prescribing plans of American medical oncologists for patients with stage IIIB non-small cell lung cancer
Mark R Green, Howard West, Mark A Socinski, et al.
American Journal of Clinical Oncology
|
February 3, 2005
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235)
Edward F McClay, Jeff Bogart, James E Herndon, et al.
Journal of Oncology Practice
|
September 28, 2010
Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data
Mark R Green, Michele Andrews, Richard Leff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 13, 2012
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection
Nichole T Tanner, Mario Gomez, Chelsea Rainwater, et al.
The Oncologist
|
January 13, 2006
How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599
Daniel Dornbusch, Carmen Allegra, Joanne Willey, et al.
Clinical Lung Cancer
|
February 22, 2007
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734
Michael C Perry, Leslie J Kohman, James A Bonner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2002
Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431
Everett E Vokes, James E Herndon, Jeffrey Crawford, et al.
Clinical Lung Cancer
|
December 10, 2003
Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430)
Alan P Lyss, James E Herndon, Thomas J Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
Ramaswamy Govindan, Robert A Kratzke, James E Herndon, et al.
The Annals of Thoracic Surgery
|
November 25, 2005
Patterns of surgical care of lung cancer patients
Alex G Little, Valerie W Rusch, James A Bonner, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 30, 2009
Impact of the ASCO 2007 presentation of HOG Lun 01-24/USO-023 on the prescribing plans of American medical oncologists for patients with stage IIIB non-small cell lung cancer
Mark R Green, Howard West, Mark A Socinski, et al.
American Journal of Clinical Oncology
|
February 3, 2005
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235)
Edward F McClay, Jeff Bogart, James E Herndon, et al.
Journal of Oncology Practice
|
September 28, 2010
Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data
Mark R Green, Michele Andrews, Richard Leff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 13, 2012
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection
Nichole T Tanner, Mario Gomez, Chelsea Rainwater, et al.
The Oncologist
|
January 13, 2006
How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599
Daniel Dornbusch, Carmen Allegra, Joanne Willey, et al.
Clinical Lung Cancer
|
February 22, 2007
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734
Michael C Perry, Leslie J Kohman, James A Bonner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2002
Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431
Everett E Vokes, James E Herndon, Jeffrey Crawford, et al.
Clinical Lung Cancer
|
December 10, 2003
Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430)
Alan P Lyss, James E Herndon, Thomas J Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
Ramaswamy Govindan, Robert A Kratzke, James E Herndon, et al.
The Annals of Thoracic Surgery
|
November 25, 2005
Patterns of surgical care of lung cancer patients
Alex G Little, Valerie W Rusch, James A Bonner, et al.
Page
of 7